USA flag logo/image

An Official Website of the United States Government

ENZYME-LINKED IMMUNOSORBENT ASSAY FOR COTININE

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
7399
Program Year/Program:
1987 / SBIR
Agency Tracking Number:
7399
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Binax Inc
95 Darling Avenue South Portland, ME 04106
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1987
Title: ENZYME-LINKED IMMUNOSORBENT ASSAY FOR COTININE
Agency: HHS
Contract: N/A
Award Amount: $42,000.00
 

Abstract:

THE LONG-TERM OBJECTIVE OF THE PROPOSED WORK IS TO PROVIDE PHYSICIANS AND OTHERS IN THE FIELD OF PREVENTIVE HEALTH CARE DELIVERY WITH AN INEXPENSIVE AND RELIABLE BIOCHEMICAL TEST TO MEASURE PATIENTS' EXPOSURE TO TOBACCO SMOKE. AT PRESENT, A RELIABLE TEST OF THIS TYPE IS NOT AVAILABLE ON A COMMERCIAL BASIS. COTININE, A METABOLITE OF NICOTINE, HAS BEEN SELECTED AS THE PRODUCT TO MEASURE BECAUSE OF ITS CHEMICAL STABILITY, SPECIFICITY AS A MARKER, AND RELATIVELY LONG CIRCULATING HALF-LIFE. HAVING ACCESS TO THIS TEST WILLENHANCE THE PROCESS OF SMOKING ABATEMENT, WHETHER GRADUAL REDUCTION TECHNIQUES (E.G., NICOTINE FADING) OR ABRUPT WITHDRAWAL ARE EMPLOYED, AND THE TEST CAN ALSO BE EMPLOYED TO EMPHASIZE TO PATIENTS THAT TOBACCO SMOKE PRODUCTS ARE ACTUALLY BEING ABSORBED INTO THE SYSTEM. AS A FIRST STEP, AN ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) WILL BE DEVELOPED TO MEASURE COTININE; IT WILL BE CAPABLE OF ASSESSING QUALITATIVELY THE EXTENT OF TOBACCO SMOKE EXPOSURE IN SALIVA AND/OR URINE. BINAX, INC. INTENDS TO TAKE ADVANTAGE OF A RECENT ADVANCE IN PRODUCING POLYCLONAL CONTININE ANTISERA THAT ALLOWS FOR SELECTIVE REMOVAL OF "BRIDGE" ANTIBODIES THAT HAVE, IN THE PAST, PRODUCED HIGH BACKGROUNDS AND DIMINISHED SENSITIVITY. TO ACHIEVE A DETECTION LIMIT OF 10 NG/ML, THE COTININE LEVEL THAT SEPARATES SMOKERS FROM NONSMOKERS, IT IS PROPOSED TO USE A SIMULTANEOUS SOLID-PHASE COMPETITIVE INHIBITION ASSAY IN WHICH BINDING OF ENZYME-LABELED COTININE ANTIBODY TO IMMOBILIZED COTININE IS COMPETITIVELY INHIBITED BY COTININE PRESENT IN THE PATIENT SAMPLE. IN PHASE II, BINAX, INC. PROPOSES TO CARRY OUT A FIELD TRIAL OF THE TEST.

Principal Investigator:

Roger n piasio
2077723544

Business Contact:

Small Business Information at Submission:

Binax Inc
95 Darling Avenue South Portland, ME 04106

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No